Recent Advances in Dementia with Lewy Bodies (DLB) and Alzheimer’s Disease (AD)
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Neurobiology".
Deadline for manuscript submissions: 31 October 2026 | Viewed by 1105
Special Issue Editor
Interests: amyloids; Alzheimer’s disease
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to announce a call for papers in a Special Issue entitled “Recent Advances in Dementia with Lewy Bodies (DLB) and Alzheimer's Disease (AD)”. The Issue aims to create a comprehensive forum for neurologists, researchers, geriatricians, and healthcare professionals to disseminate cutting-edge findings. We welcome submissions on a broad range of topics, including but not limited to, the following:
- Novel disease-modifying therapies: Anti-amyloid, anti-tau, and anti-alpha-synuclein approaches; immunotherapies; and targeted small molecules.
- Symptomatic treatment innovations: Advanced management of cognitive, psychiatric, and motor symptoms.
- Biomarker-driven treatment: The role of PET, CSF, and blood-based biomarkers in diagnosis, patient selection, and monitoring treatment efficacy and safety.
- Other molecular mechanisms/pathways: The application of digital health and other technologies to these diseases.
We invite the submission of original research articles, systematic reviews, meta-analyses, and case series that push the boundaries of our understanding and pave the way for the next generation of dementia care.
Prof. Dr. Yuan-Han Yang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- dementia with Lewy bodies
- Alzheimer's disease
- amyloid
- tau
- alpha-synuclein
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
